Dihydroartemisinin inhibits IL-6-induced epithelial–mesenchymal transition in laryngeal squamous cell carcinoma via the miR-130b-3p/STAT3/β-catenin signaling pathway

OBJECTIVE: To explore whether dihydroartemisinin (DHA) can block interleukin (IL)-6-induced epithelial–mesenchymal transition (EMT) in laryngeal squamous cell carcinoma (LSCC). METHODS: The expression of SLUG, signal transducer and activator of transcription 3 (STAT3), and microRNA (miR)-130b-3p was...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Yajing, Lu, Xiuying, Li, Hui, Li, Xiaoming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Pre-Clinical Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8586195/
https://www.ncbi.nlm.nih.gov/pubmed/34755560
http://dx.doi.org/10.1177/03000605211009494

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8586195/
https://www.ncbi.nlm.nih.gov/pubmed/34755560
http://dx.doi.org/10.1177/03000605211009494

Ejemplares similares